Citation Impact
Citing Papers
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Absence Epilepsy in Tottering Mutant Mice Is Associated with Calcium Channel Defects
1996
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cancer immunotherapy: the beginning of the end of cancer?
2016
Expression of synaptotagmin and syntaxin associated with N‐type calcium channels in small cell lung cancer
1993
.alpha.-Bungarotoxin and the competing antibody WF6 interact with different amino acids within the same cholinergic subsite
1991
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Myasthenia Gravis
1988
Plasma Exchange in Neuroimmunological Disorders
2006
Myasthenia Gravis
2016 Standout
Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments
2003
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 Standout
ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity
2001
Cytokines and the pathogenesis of myasthenia gravis
1997
Cloning and expression in Escherichia coli of a synthetic gene encoding the extracellular domain of the human muscle acetylcholine receptor α-subunit
1991
The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies
1991
Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma
2002
The biology and management of non-small cell lung cancer
2018 StandoutNature
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Guillain-Barré syndrome
2016 Standout
Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4
1996 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Autoantibody Specificities in Lambert‐Eaton Myasthenic Syndrome
1993
Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.
1991
Neuromuscular junction disorders
2016
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors
2000
Effects of mutations of Torpedo acetylcholine receptor .alpha.1 subunit residues 184-200 on .alpha.-bungarotoxin binding in a recombinant fusion protein
1993
P/Q-type Ca2+ channel defects in migraine, ataxia and epilepsy
1998
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
1988
Multiple sclerosis
2008 Standout
Myasthenia Gravis
1994 Standout
Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals
1998
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
1991 StandoutNature
Immunotherapy in autoimmune neuromuscular disorders
2002
Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravisa
1987
Homologous .kappa.-neurotoxins exhibit residue-specific interactions with the .alpha.3 subunit of the nicotinic acetylcholine receptor: A comparison of the structural requirements for .kappa.-bungarotoxin and .kappa.-flavitoxin binding
1993
Copper transport
1998
Migraine — Current Understanding and Treatment
2002 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Substitution of Torpedo acetylcholine receptor .alpha.1-subunit residues with snake .alpha.1- and rat nerve .alpha.3-subunit residues in recombinant fusion proteins: effect on .alpha.-bungarotoxin binding
1992
Humoral Pathogenesis of Myasthenia Grayisa
1987
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer
2003
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy
2004
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
2011
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
2002 Standout
Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction
2009
Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor
2000
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Understanding and altering cell tropism of vesicular stomatitis virus
2013
The PI3K Pathway in Human Disease
2017 Standout
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
2001 StandoutNature
Ca2+-dependent Interaction of Recoverin with Rhodopsin Kinase
1995 StandoutNobel
Association of Neuronal Calcium Channels with Modular Adaptor Proteins
1999 StandoutNobel
Polymyositis and dermatomyositis
2003 Standout
Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients
1990
Amyotrophic Lateral Sclerosis
2001 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Guillain-Barré syndrome
2005 Standout
Nuclear magnetic resonance solution structure of the α-neurotoxin from the black mamba (Dendroaspis polylepis polylepis)
1992 StandoutNobel
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Nuclear Magnetic Resonance (NMR) Analysis of Ligand Receptor Interactions: The Cholinergic System — A Model
1996
T-cell reactivity in myasthenia gravis
1989
Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody‐binding epitopes in myasthenia gravis
2013
New Purkinje cell antibody (PCA-2): Marker of lung cancer-related neurological autoimmunity
2000
Antibody-Mediated Encephalitis
2018 Standout
Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines.
1993
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer
2002
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
B7x: A widely expressed B7 family member that inhibits T cell activation
2003 StandoutNobel
ADrosophilaCalcium Channel α1 Subunit Gene Maps to a Genetic Locus Associated with Behavioral and Visual Defects
1996 StandoutNobel
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.
1996
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
The Cation−π Interaction
1997 Standout
A sequence pattern common to T cell epitopes.
1988
Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction
2003 StandoutNobel
Mouse VAP33 is associated with the endoplasmic reticulum and microtubules
2000 StandoutNobel
Molecular cloning of the alpha-1 subunit of an omega-conotoxin-sensitive calcium channel.
1992
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses
1997 StandoutNobel
Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells
2003 StandoutNobel
Amyotrophic lateral sclerosis and antibodies to voltage‐gated calcium channels—new doubts
1996
Advances in Copper Complexes as Anticancer Agents
2013 Standout
A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy.
1991
Isoform-specific interaction of the alpha1A subunits of brain Ca2+ channels with the presynaptic proteins syntaxin and SNAP-25.
1996
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
Works of Guy E. Griesmann being referenced
PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
2013
Molecular Diversity of Neuronal-Type Calcium Channels Identified in Small Cell Lung Carcinoma
1992
Nine Residues Influence the Binding of α‐Bungarotoxin in α‐Subunit Region 185–200 of Human Muscle Acetylcholine Receptor
1993
α‐Bungarotoxin Binds to Human Acetylcholine Receptor α‐Subunit Peptide 185–199 in Solution and Solid Phase but Not to Peptides 125–147 and 389–409
1990
Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes
1995
Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide
2007
Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates
2009
Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis
1989
Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
1988
Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
1985
Reply
2001
Immunoglobulin G Antibody-Mediated Enhancement of Measles Virus Infection Can Bypass the Protective Antiviral Immune Response
2006
Myasthenogenicity of human acetylcholine receptor synthetic alpha-subunit peptide 125-147 does not require intramolecular disulfide cyclization.
1987
CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity
2001
Copper and ceruloplasmin activity in human amniotic fluid
1980
CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity
2001